Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Filing tables
Filing exhibits
Related press release
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statement (Form S-8 No. 333-262128) pertaining to the 2019 Stock Option Plan, 2022 Equity Incentive Plan, and 2022 Employee Stock Purchase Plan of our report dated March 22, 2022, with respect to the financial statements of CinCor Pharma, Inc. included in this Annual Report (Form 10-K) of CinCor Pharma, Inc. for the year ended December 31, 2021.
/s/ Ernst & Young LLP
Cincinnati, Ohio
March 22, 2022